SCHEMBL25796037

SCHEMBL25796037

BC(C)(C)c1cnc(-c2ccc(C)cc2)cc1C(B)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 1/20 0.37
▸ CYP11B2 P19099 1/20 0.37
▸ METAP2 P50579 1/20 0.37
▸ METAP1 P53582 1/20 0.37
▸ KDM1A O60341 2/20 0.36
▸ CCR1 P32246 1/20 0.36
▸ CCR5 P51681 1/20 0.36
▸ CCR8 P51685 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ KMT2A Q03164 5/20 0.35
▸ MEN1 O00255 4/20 0.35
▸ LMNA P02545 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ HDAC1 Q13547 2/20 0.34
▸ POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22080319 0.84 LDHA (0.42) KMT2AMEN1KDM4EALDH1A1NPC1
SCHEMBL22675050 0.82 METAP2 (0.39) CYP11B1CYP11B2METAP2METAP1KDM1A
SCHEMBL22080172 0.77 LDHA (0.39) CYP11B1CYP11B2METAP2METAP1KDM1A
SCHEMBL23561573 0.77 CYP11B1 (0.35) CYP11B1CYP11B2METAP2METAP1KDM1A
SCHEMBL25455629 0.77 CYP11B1 (0.35) CYP11B1CYP11B2METAP2METAP1KDM1A
SCHEMBL25798075 0.75 SDHB (0.33) CYP11B1CYP11B2METAP2METAP1KDM1A
SCHEMBL18729621 0.74 CCR1 (0.44) METAP2METAP1KDM1ACCR1CCR5
SCHEMBL24913293 0.73 CYP1A2 (0.43) METAP2KMT2AMEN1LMNAKDM4E
SCHEMBL24066428 0.72 LDHA (0.36) CYP11B1CYP11B2METAP2METAP1KDM1A
SCHEMBL22079793 0.72 LDHA (0.36) CYP11B1CYP11B2METAP2METAP1KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827651-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-11-28 — — US disclosed
US-11697653-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-07-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11697653-B2 Organic electroluminescent materials and devices L1CAM, SOD1, EPCAM CYP11B1 1966/4885CYP11B2 1838/4885METAP2 3604/4885
US-11827651-B2 Organic electroluminescent materials and devices SSB, L1CAM, LEF1 CYP11B1 4369/4885CYP11B2 4211/4885METAP2 3798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback